Skip to main content

Table 1 Schedule of assessments

From: Endovenous laser ablation versus mechanochemical ablation with ClariVein® in the management of superficial venous insufficiency (LAMA trial): study protocol for a randomised controlled trial

Visits

1

2

3

4

5

6

Procedures

Screening, eligibility, baseline assessment and randomisation

Treatment

1-week follow-up

6-week follow-up

6-month follow-up

1-year follow-up

Medication history

X

X

X

X

X

X

Medications

X

X

X

X

X

X

Physical examination

X

X

X

X

X

X

NS-SEC

X

     

Employment status

X

     

Informed consent

X

     

CEAP

X

 

X

X

X

X

VCSS

X

 

X

X

X

X

AVVQ

X

 

X

X

X

X

CIVIQ-20

X

 

X

X

X

X

VEINES-QOL/Sym

X

 

X

X

X

X

SF-36

X

 

X

X

X

X

EQ5D

X

 

X

X

X

X

DUS

X

 

X

X

X

X

Pain VAS

 

X

X

X

X

X

Analgesia diary

 

X

X

X

X

X

Satisfaction VAS

  

X

X

X

X

Cosmesis VAS

  

X

X

X

X

Recovery time

  

X

X

X

X

Complications

  

X

X

X

X

  1. NS-SEC National Statistics Socio-Economic Classification, CEAP Clinical severity, Etiology, Anatomy and Pathophysiology, VCSS Venous Clinical Severity Score, AVVQ Aberdeen Varicose Vein Questionnaire, CIVIQ-20 Chronic Venous Insufficiency Questionnaire, VEINES-QOL/Sym VEnous INsufficiency Epidemiological and Economic Study to evaluate Quality of Life and Symptoms, SF-36 Short Form 36-item, EQ5D EuroQol 5-domain utility index, DUS duplex ultrasound, VAS visual analogue scale
Back to article page

Trials

ISSN: 1745-6215